APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intranasal Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intranasal Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchIntranasal Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Intranasal Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Intranasal Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intranasal Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Intranasal Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Intranasal Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intranasal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intranasal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intranasal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intranasal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intranasal Vaccine include Abbott, Beijing Wantai Biopharmaceutical Co., Ltd., Sanofi, GlaxoSmithKline, Changchun Baike Company, AstraZeneca, Serum Institute of India, PharmaJet and Crossject and INJEX Pharma GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intranasal Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intranasal Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intranasal Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intranasal Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Intranasal Vaccine Segment by Company

Abbott

Beijing Wantai Biopharmaceutical Co., Ltd.

Sanofi

GlaxoSmithKline

Changchun Baike Company

AstraZeneca

Serum Institute of India

PharmaJet and Crossject

INJEX Pharma GmbH

BioDiem

Bharat Biotech

Antares Pharma

Intranasal Vaccine Segment by Type

Flu Vaccine

COVID-19 Vaccines

Intranasal Vaccine Segment by Application

Hospital

Clinic

Intranasal Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intranasal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intranasal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intranasal Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intranasal Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intranasal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intranasal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intranasal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intranasal Vaccine Industry Trends Table 2. Intranasal Vaccine Industry Drivers Table 3. Intranasal Vaccine Industry Opportunities and Challenges Table 4. Intranasal Vaccine Industry Restraints Table 5. Global Intranasal Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intranasal Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intranasal Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Intranasal Vaccine Sales Market Share by Manufacturers Table 9. Global Intranasal Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Intranasal Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intranasal Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intranasal Vaccine Manufacturers, Product Type & Application Table 13. Global Intranasal Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intranasal Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Flu Vaccine Table 17. Major Manufacturers of COVID-19 Vaccines Table 18. Global Intranasal Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Intranasal Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Intranasal Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Intranasal Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Intranasal Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Intranasal Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Intranasal Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Intranasal Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Intranasal Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Intranasal Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Intranasal Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Intranasal Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Intranasal Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Intranasal Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Intranasal Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Intranasal Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Intranasal Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Intranasal Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Intranasal Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Intranasal Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Intranasal Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Intranasal Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Intranasal Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Intranasal Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Intranasal Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Intranasal Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Intranasal Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Intranasal Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Intranasal Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Intranasal Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Intranasal Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Intranasal Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Intranasal Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Intranasal Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Intranasal Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Intranasal Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Intranasal Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Intranasal Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Intranasal Vaccine Revenue Market Share by Region (2027-2032) Table 62. Abbott Company Information Table 63. Abbott Business Overview Table 64. Abbott Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Abbott Intranasal Vaccine Product Portfolio Table 66. Abbott Recent Development Table 67. Beijing Wantai Biopharmaceutical Co., Ltd. Company Information Table 68. Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview Table 69. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio Table 71. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sanofi Intranasal Vaccine Product Portfolio Table 76. Sanofi Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Intranasal Vaccine Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. Changchun Baike Company Company Information Table 83. Changchun Baike Company Business Overview Table 84. Changchun Baike Company Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Changchun Baike Company Intranasal Vaccine Product Portfolio Table 86. Changchun Baike Company Recent Development Table 87. AstraZeneca Company Information Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. AstraZeneca Intranasal Vaccine Product Portfolio Table 91. AstraZeneca Recent Development Table 92. Serum Institute of India Company Information Table 93. Serum Institute of India Business Overview Table 94. Serum Institute of India Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Serum Institute of India Intranasal Vaccine Product Portfolio Table 96. Serum Institute of India Recent Development Table 97. PharmaJet and Crossject Company Information Table 98. PharmaJet and Crossject Business Overview Table 99. PharmaJet and Crossject Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. PharmaJet and Crossject Intranasal Vaccine Product Portfolio Table 101. PharmaJet and Crossject Recent Development Table 102. INJEX Pharma GmbH Company Information Table 103. INJEX Pharma GmbH Business Overview Table 104. INJEX Pharma GmbH Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. INJEX Pharma GmbH Intranasal Vaccine Product Portfolio Table 106. INJEX Pharma GmbH Recent Development Table 107. BioDiem Company Information Table 108. BioDiem Business Overview Table 109. BioDiem Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. BioDiem Intranasal Vaccine Product Portfolio Table 111. BioDiem Recent Development Table 112. Bharat Biotech Company Information Table 113. Bharat Biotech Business Overview Table 114. Bharat Biotech Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Bharat Biotech Intranasal Vaccine Product Portfolio Table 116. Bharat Biotech Recent Development Table 117. Antares Pharma Company Information Table 118. Antares Pharma Business Overview Table 119. Antares Pharma Intranasal Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Antares Pharma Intranasal Vaccine Product Portfolio Table 121. Antares Pharma Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Intranasal Vaccine Distributors List Table 125. Intranasal Vaccine Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Intranasal Vaccine Product Image Figure 2. Global Intranasal Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intranasal Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Intranasal Vaccine Sales (2021-2032) & (k units) Figure 5. Global Intranasal Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Intranasal Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Flu Vaccine Image Figure 9. COVID-19 Vaccines Image Figure 10. Global Intranasal Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Intranasal Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Intranasal Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Intranasal Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Intranasal Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Intranasal Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Intranasal Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Intranasal Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Intranasal Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Intranasal Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Intranasal Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Intranasal Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Intranasal Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Intranasal Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Intranasal Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Intranasal Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Intranasal Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Intranasal Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Intranasal Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Intranasal Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Intranasal Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Intranasal Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Intranasal Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Intranasal Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Intranasal Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Intranasal Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Flu Vaccine
  • COVID-19 Vaccines
Applications
  • Hospital
  • Clinic
Companies covered
  • Abbott
  • Beijing Wantai Biopharmaceutical Co., Ltd.
  • Sanofi
  • GlaxoSmithKline
  • Changchun Baike Company
  • AstraZeneca
  • Serum Institute of India
  • PharmaJet and Crossject
  • INJEX Pharma GmbH
  • BioDiem
  • Bharat Biotech
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intranasal Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intranasal Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intranasal Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intranasal Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intranasal Vaccine Market Dynamics
  1. 2.1 Intranasal Vaccine Industry Trends
  2. 2.2 Intranasal Vaccine Industry Drivers
  3. 2.3 Intranasal Vaccine Industry Opportunities and Challenges
  4. 2.4 Intranasal Vaccine Industry Restraints
3 Intranasal Vaccine Market by Manufacturers
  1. 3.1 Global Intranasal Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intranasal Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intranasal Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intranasal Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intranasal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intranasal Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Intranasal Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intranasal Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intranasal Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intranasal Vaccine Tier 1, Tier 2, and Tier 3
4 Intranasal Vaccine Market by Type
  1. 4.1 Intranasal Vaccine Type Introduction
  2. 4.1.1 Flu Vaccine
  3. 4.1.2 COVID-19 Vaccines
  4. 4.2 Global Intranasal Vaccine Sales by Type
  5. 4.2.1 Global Intranasal Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Intranasal Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Intranasal Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Intranasal Vaccine Revenue by Type
  9. 4.3.1 Global Intranasal Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Intranasal Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Intranasal Vaccine Revenue Market Share by Type (2021-2032)
5 Intranasal Vaccine Market by Application
  1. 5.1 Intranasal Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Intranasal Vaccine Sales by Application
  5. 5.2.1 Global Intranasal Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Intranasal Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Intranasal Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Intranasal Vaccine Revenue by Application
  9. 5.3.1 Global Intranasal Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Intranasal Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Intranasal Vaccine Revenue Market Share by Application (2021-2032)
6 Global Intranasal Vaccine Sales by Region
  1. 6.1 Global Intranasal Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intranasal Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Intranasal Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Intranasal Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intranasal Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intranasal Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intranasal Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intranasal Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intranasal Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intranasal Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intranasal Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intranasal Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intranasal Vaccine Revenue by Region
  1. 7.1 Global Intranasal Vaccine Revenue by Region
  2. 7.1.1 Global Intranasal Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intranasal Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Intranasal Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Intranasal Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intranasal Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Intranasal Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intranasal Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Intranasal Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intranasal Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intranasal Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intranasal Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intranasal Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Intranasal Vaccine Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Beijing Wantai Biopharmaceutical Co., Ltd.
  8. 8.2.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio
  12. 8.2.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Intranasal Vaccine Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Intranasal Vaccine Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Changchun Baike Company
  26. 8.5.1 Changchun Baike Company Company Information
  27. 8.5.2 Changchun Baike Company Business Overview
  28. 8.5.3 Changchun Baike Company Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Changchun Baike Company Intranasal Vaccine Product Portfolio
  30. 8.5.5 Changchun Baike Company Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Intranasal Vaccine Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 Serum Institute of India
  38. 8.7.1 Serum Institute of India Company Information
  39. 8.7.2 Serum Institute of India Business Overview
  40. 8.7.3 Serum Institute of India Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Serum Institute of India Intranasal Vaccine Product Portfolio
  42. 8.7.5 Serum Institute of India Recent Developments
  43. 8.8 PharmaJet and Crossject
  44. 8.8.1 PharmaJet and Crossject Company Information
  45. 8.8.2 PharmaJet and Crossject Business Overview
  46. 8.8.3 PharmaJet and Crossject Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PharmaJet and Crossject Intranasal Vaccine Product Portfolio
  48. 8.8.5 PharmaJet and Crossject Recent Developments
  49. 8.9 INJEX Pharma GmbH
  50. 8.9.1 INJEX Pharma GmbH Company Information
  51. 8.9.2 INJEX Pharma GmbH Business Overview
  52. 8.9.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 INJEX Pharma GmbH Intranasal Vaccine Product Portfolio
  54. 8.9.5 INJEX Pharma GmbH Recent Developments
  55. 8.10 BioDiem
  56. 8.10.1 BioDiem Company Information
  57. 8.10.2 BioDiem Business Overview
  58. 8.10.3 BioDiem Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BioDiem Intranasal Vaccine Product Portfolio
  60. 8.10.5 BioDiem Recent Developments
  61. 8.11 Bharat Biotech
  62. 8.11.1 Bharat Biotech Company Information
  63. 8.11.2 Bharat Biotech Business Overview
  64. 8.11.3 Bharat Biotech Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bharat Biotech Intranasal Vaccine Product Portfolio
  66. 8.11.5 Bharat Biotech Recent Developments
  67. 8.12 Antares Pharma
  68. 8.12.1 Antares Pharma Company Information
  69. 8.12.2 Antares Pharma Business Overview
  70. 8.12.3 Antares Pharma Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Antares Pharma Intranasal Vaccine Product Portfolio
  72. 8.12.5 Antares Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intranasal Vaccine Value Chain Analysis
  2. 9.1.1 Intranasal Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intranasal Vaccine Production Mode & Process
  6. 9.2 Intranasal Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intranasal Vaccine Distributors
  9. 9.2.3 Intranasal Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst